Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy.

Viruses - 21 Apr 2021

Liu Pei, Yuan Yadi, Cui Bopei, Huo Yaqian, Bian Lianlian, Chen Lei, Liu Siyuan, Wang Chenfei, Xu Yingzhi, Tedcastle Alison, Gao Fan, Mao Qunying, Martin Javier, Liang Zhenglun

Abstract excerpt

Enterovirus A-71 (EV71) is a global, highly contagkkious pathogen responsible for severe cases of hand-food-mouth-disease (HFMD). The use of vaccines eliciting cross neutralizing antibodies (NTAbs) against the different circulating EV71 sub-genotypes is important for preventing HFMD outbreaks. Here, we tested the cross-neutralizing activities induced by EV71 genotype/sub-genotype A, B0-B4, C1, C2, C4, and C5...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Cross Reactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enterovirus A, Human

Share to Enterovirus Infections

Share to Immunogenicity, Vaccine

Share to Neutralization Tests

Share to Vaccines, Inactivated

Share to Viral Vaccines

Source

Open in PubMed Open full text

Identifiers

PMID: 33919184
DOI: 10.3390/v13050720
PMCID: PMC8143144

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy.PMID 33919184Read ↗

The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children.Semantic proximity Read ↗

Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007.Semantic proximity Read ↗

Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assay.Semantic proximity Read ↗

Cross-reactive neutralizing antibody responses to enterovirus 71 infections in young children: implications for vaccine development.Semantic proximity Read ↗

Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: current genotyping of EV71 does not reflect their antigenicity.Semantic proximity Read ↗

Antigenic and genetic diversity of human enterovirus 71 from 2009 to 2012, Taiwan.Semantic proximity Read ↗

Development of a high-growth enterovirus 71 vaccine candidate inducing cross-reactive neutralizing antibody responses.Semantic proximity Read ↗

Cross-Reactive Antibody Responses against Nonpoliovirus EnterovirusesSemantic proximity Read ↗

Neutralization of African enterovirus A71 genogroups by antibodies to canonical genogroups.Semantic proximity Read ↗

Establishment of an animal challenge model as a potency assay for an inactivated Enterovirus Type 71 vaccine.Semantic proximity Read ↗

Chimeric Virus-Like Particle Vaccines Displaying Conserved Enterovirus 71 Epitopes Elicit Protective Neutralizing Antibodies in Mice through Divergent MechanismsSemantic proximity Read ↗

TAK - 021, an inactivated Enterovirus 71 vaccine candidate, provides cross-protection against heterologous sub-genogroups in human scavenger receptor B2 transgenic mice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.